Validation of the TruSight One Sequencing Panel for Clinical Research

You’re invited to the Illumina User Group Meeting in New York City on Tuesday, October 9, 2018, 8:00 AM – 5:00 PM, where we will share about the progress being made using Illumina Next-Generation Sequencing and Array technology. You’ll hear from researchers like you about the discoveries they have made with genomic technology and how they continue to move the needle in our joint quest to unlock the power of the human genome.

Illumina User Group Meetings provide an invaluable forum to learn how the latest technology and methods can accelerate your discoveries.

Speakers:

• Ami Bhatt, MD, PhD, Assistant Professor of Medicine and of Genetics, Stanford
• Jason Buenrostro, PhD, Broad Institute Fellow of MIT and Harvard, Harvard Society of Fellows, Junior Fellow, Broad Institute of MIT and Harvard
• Olga Dudchenko, PhD, Postdoctoral Associate, Molecular & Human Genetics, Aiden Lab, Baylor College of Medicine
• Alison Goate, DPhil, Professor of Neuroscience; Director of Ronald M. Loeb Center
• Shareef Nahas, PhD, FACMG, CGMB Senior Director Clinical Laboratory Operations, Rady Children’s Institute for Genomic Medicine
• Matija Snuderl, MD, Assistant Professor, Department of Pathology; Director, Molecular Pathology, NYU Langone Medical Center and Medical School
• Kathleen C Barnes, PhD, Director, Colorado Center for Personalized Medicine, Head Division of Biomedical Informatics & Personalized Medicine, University of Colorado, Department of Medicine
• Aboli Rane, PhD, Sr Regional Segment Manager, Genetic Disease Research, Illumina, Inc.
• Maude Champagne, MBA, Commercial Development, Oncology, Illumina, Inc.
• Britt Flaherty, PhD, Executive Sequencing Specialist, Illumina, Inc.
• Kevin Taylor, PhD, Sr Manager, Complex Disease, Illumina, Inc.

Join us for:

• Illumina product updates, including the NovaSeq™ system and our investment in the future of genomics.
• New research from your peers using the latest technology: topics include single cell sequencing, genome structures, and complex disease research.
• Hot topics in precision medicine, including methylation-based tumor classification, implementation of population screening with arrays, and critical updates on the microbiome.
• Genetic Energy Expo to learn about new solutions from Illumina and our partners, and an opportunity to connect with technical experts or engage in discussions with your peers.

Who Should Attend:

Illumina User Group Meetings are exclusively for those who own, use, or have their data generated on Illumina instrumentation. The presentations will cover a broad range of applications, and are designed for new or experienced users in the areas of optimization of the sequencing workflow or bioinformatics.